Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Edecesertib is an inhibitor of IL-1 receptor-associated kinase 4 (IRAK4; IC50 = 0.6 nM).1 It is selective for IRAK4 over a panel of 484 additional kinases at 1,000 nM. Edecesertib inhibits toll-like receptor 7 (TLR7) agonist-induced IFN-α production in isolated human whole blood (IC50 = 124 nM). Dietary administration of edecesertib (0.07% w/w in chow) reduces proteinuria and decreases plasma levels of TNF-α and IL-12 in an NZBWF1 mouse model of systemic lupus erythematosus (SLE).
WARNING This product is not for human or veterinary use.
1. Discovery of edecesertib (GS-